Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

809556

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Contraceptives: Pregnancy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if the Medicines and Healthcare Products Regulatory Agency will review the description in ellaOne packaging that states that if you are already pregnant, it [ellaOne] will not interrupt an existing pregnancy.
tabling member constituency	Congleton
tabling member printed	Fiona Bruce
uin	120214
answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>EllaOne is an ulipristal acetate-containing emergency hormonal contraceptive that is licensed for use within five days of unprotected sexual intercourse or contraceptive failure. It is classified as a female emergency contraceptive; it is not an abortifacient. It exerts its contraceptive action by preventing or delaying ovulation. EllaOne has never been studied as an abortifacient. It is not intended for use during pregnancy and should not be taken by any woman suspected or known to be pregnant. The information provided in each pack of ellaOne clearly informs women and healthcare professionals that it should not be taken by a woman who knows or suspect she is pregnant.</p><p> </p><p>The requirements for medicines labelling are set out within Title V of Council Directive 2001/83/EC. As ellaOne is authorised throughout the European Union the labelling particulars are agreed across all member states by the European Medicines Agency. The Medicines and Healthcare products Regulatory Agency will be liaising with the European Medicines Agency to discuss whether any changes might be desirable within the terms of the marketing authorisation.</p><p> </p><p>As with all other licensed medicines, the Medicines and Healthcare products Regulatory Agency keeps the safety of ellaOne under close review using a wide number of data sources.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:07:57 answering member 4067 label Biography information for Steve Brine
tabling member	3958 label Biography information for Fiona Bruce

809659

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to Age UK’s Painful Journeys campaign, what steps his Department is taking to make travelling to and from hospital easier for older people.
tabling member constituency	Sheffield Central
tabling member printed	Paul Blomfield
uin	120279
answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>The provision of appropriate patient transport services (PTS) in line with national guidance is a matter for local National Health Service commissioners.</p><p> </p><p>The Department is clear that medically eligible patients must have appropriate access to quality PTS to outpatient appointments. The document ‘Eligibility Criteria for Patient Transport Services’ sets out criteria for establishing which patients are eligible for non-emergency PTS. The guidance states that eligible patients should reach appointments in reasonable time and in reasonable comfort, without detriment to their medical condition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:03:11 answering member 4067 label Biography information for Steve Brine
tabling member	4058 label Biography information for Paul Blomfield